Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports

Group 1 - Kenvue's interim CEO Kirk Perry met with Robert F. Kennedy Jr. to discuss concerns regarding Tylenol's potential link to autism [1] - The meeting aimed to persuade the U.S. health secretary against including Tylenol as a possible cause of autism in an upcoming report [1] - This engagement highlights Kenvue's proactive approach in addressing public health concerns related to its products [1] Group 2 - The discussion reflects the ongoing scrutiny and debate surrounding the safety of over-the-counter medications like Tylenol [1] - Kenvue is positioned to navigate potential regulatory challenges that may arise from the report's findings [1] - The outcome of this meeting could have significant implications for Kenvue's reputation and market performance [1]